Clinical Trial

Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB)

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated July 29, 2026 (before its estimated August 2, 2026 completion). Its status may not reflect the trial's current state.
Summary
The study is to evaluate the efficacy and safety of AHB-137 in CHB participants. The total duration of the study, including screening phase, treatment phase and follow-up phase.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-02-11; most recent amendment 2026-05-01.
Status change: Recruiting → Active, Not Recruiting 2025-09-22
Trial Details
NCT Number NCT06829329
Lead Sponsor Ausper Biopharma Co., Ltd.
Conditions Chronic Hepatitis B
Enrollment 105 participants
Start Date 2024-12-13
Primary Completion 2026-08-02 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-29